Germany Ophthalmology Therapeutics Market: Segmented by Route of Administration, Dosage Form, Indication and Drug Class - Growth, Trends, and Forecasts (2019 2028)
- Published Date: 2022-12-28
- Report ID: 139847
- Pages: 200
-
Format:
Report Overview
Germanys Ophthalmology Therapeutics market size stood at around USD XX.X billion in 2019 and is projected to reach USD XX billion by 2028, exhibiting a CAGR of around 4.9% during the forecast period.
Germany's ophthalmology therapeutics market growth attributes due to the prevalence of diabetes and glaucoma in the region. Increasing incidence of vision impairment, Advancements in technology in the field of medicine & g geriatric population across the country along with an increase in disposable income of the people are some of the factors adding up to the industry growth. Also growing awareness among the masses for regular check-ups for early detection of eye disorders is also leading the market growth.
Market Driving and Restraining Factors
Market Drivers
An increasing number of people suffering from diabetes and glaucoma, increasing incidence of vision impairment, high innovation, and heavy funding in the development of combination therapies are the major factors driving the growth of this market.
Restraining Factors
Stringent regulatory framework and unclear reimbursement policies are also acting as hurdles for Industry growth. Lack of awareness about various diseases associated with ophthalmology is also a major restraint hindering Industry growth. Adverse side-effects and long gestation periods in the development of new drugs hamper the market growth.
1. Germany Ophthalmology Therapeutics Market Overview..........
A. Market Size
2. Market Driving and Restraining Factors .
A. Market Drivers
a. Prevalence of Diabetes and Glaucoma
b. Increasing incidence of vision impairment
c. High Innovation
d. Heavy Funding
B. Restraining Factors
a. Stringent Regulatory Framework
b. Unclear reimbursement policies
c. Lack of awareness about diseases associated
d. Side-effects and Long gestation periods of new drugs
3. Major Ophthalmology diseases
A. Dry Eye
B. Eye Allergies
C. Glaucoma
D. Eye Infection
E. Retinal disorders
F. Uveitis
G. Others
4. Ophthalmology Therapeutics Market Segmentation...........
A. By Ways of Administration
a. Topical
b. Local Ocular
c. Subconjunctival
d. Intravitreal
e. Retrobulbar
f. Intracameral
g. Systemic
B. By Dosage Form
a. Gels
b. Eye Solutions
c. Capsules & Tablets
d. Eye Drops
e. Ointments
C. By Indication
a. Glaucoma.
b. Dry Eye Syndrome.
c. Diabetic Retinopathy.
d. Retinal Vein Occlusion.
e. Age-Related Macular Degeneration.
f. Macular Edema.
g. Allergic Conjunctivitis.
D. By Drug Class
a. Antiallergy
b. Anti-VEGF Agents
c. Anti-inflammatory
d. Nonsteroidal Drugs
e. Steroidal Drugs
f. Antiglaucoma
5. Ophthalmology Major Products Market Share
A. Market Analysis, Insights and Forecast By Revenue
6. Competitive Landscape...
A. Major Players
B. Products in Pipeline
7. Key Company Profiles..
A. Allergan GMbH Company overview, Product & Services, Strategies & Financials
B. Ciba Vision GmbH Company overview, Product & Services, Strategies & Financials
C. Pfizer Company overview, Product & Services, Strategies & Financials
D. Merck & co. Inc. Company overview, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth
A. New Trends and Developments
B. Future Opportunities
10. Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
